Menichella Daniel L 4
4 · Kaleido Biosciences, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Menichella Daniel L
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+70,200→ 70,200 total→ Common Stock (70,200 underlying) - Award
Restricted Stock Units
2022-01-14+250,000→ 250,000 total→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
- [F3]The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.